Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stije J. Leopold is active.

Publication


Featured researches published by Stije J. Leopold.


Clinical Infectious Diseases | 2018

Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial

Katherine Plewes; Hugh W. F. Kingston; Aniruddha Ghose; Thanaporn Wattanakul; Mahtab Uddin Hassan; Shafiul Haider; Prodip Kumar Dutta; Akhterul Islam; Shamsul Alam; Selim Md Jahangir; Abu Shahed Md Zahed; Abdus Sattar; Ma Hassan Chowdhury; M. Trent Herdman; Stije J. Leopold; Haruhiko Ishioka; Kim A. Piera; Prakaykaew Charunwatthana; Kamolrat Silamut; Tsin W. Yeo; Sue J. Lee; Mavuto Mukaka; Richard J. Maude; Gareth D. H. Turner; Abul Faiz; Joel Tarning; John A. Oates; Nicholas M. Anstey; Nicholas J. White; Nicholas P. J. Day

This randomized, controlled trial shows that acetaminophen reduces kidney dysfunction and risk of developing acute kidney injury, particularly in severe malaria patients who present with high plasma hemoglobin, supporting the hypothesis that acetaminophen inhibits cell-free hemoglobin-mediated renal tubular oxidative damage.


PLOS ONE | 2017

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

Atthanee Jeeyapant; Hugh W. F. Kingston; Katherine Plewes; Richard J. Maude; Josh Hanson; M. Trent Herdman; Stije J. Leopold; Thatsanun Ngernseng; Prakaykaew Charunwatthana; Nguyen Hoan Phu; Aniruddha Ghose; Caterina I. Fanello; Abul Faiz; Tran Tinh Hien; Nicholas P. J. Day; Nicholas J. White; Arjen M. Dondorp

Background Clinical trials in severe falciparum malaria require a large sample size to detect clinically meaningful differences in mortality. This means few interventions can be evaluated at any time. Using a validated surrogate endpoint for mortality would provide a useful alternative allowing a smaller sample size. Here we evaluate changes in coma score and plasma lactate as surrogate endpoints for mortality in severe falciparum malaria. Methods Three datasets of clinical studies in severe malaria were re-evaluated: studies from Chittagong, Bangladesh (adults), the African ‘AQUAMAT’ trial comparing artesunate and quinine (children), and the Vietnamese ‘AQ’ study (adults) comparing artemether with quinine. The absolute change, relative change, slope of the normalization over time, and time to normalization were derived from sequential measurements of plasma lactate and coma score, and validated for their use as surrogate endpoint, including the proportion of treatment effect on mortality explained (PTE) by these surrogate measures. Results Improvements in lactate concentration or coma scores over the first 24 hours of admission, were strongly prognostic for survival in all datasets. In hyperlactataemic patients in the AQ study (n = 173), lower mortality with artemether compared to quinine closely correlated with faster reduction in plasma lactate concentration, with a high PTE of the relative change in plasma lactate at 8 and 12 hours of 0.81 and 0.75, respectively. In paediatric patients enrolled in the ‘AQUAMAT’ study with cerebral malaria (n = 785), mortality was lower with artesunate compared to quinine, but this was not associated with faster coma recovery. Conclusions The relative changes in plasma lactate concentration assessed at 8 or 12 hours after admission are valid surrogate endpoints for severe malaria studies on antimalarial drugs or adjuvant treatments aiming at improving the microcirculation. Measures of coma recovery are not valid surrogate endpoints for mortality.


Malaria Journal | 2017

Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria

Katherine Plewes; Ingfar Soontarawirat; Aniruddha Ghose; Germana Bancone; Hugh W. F. Kingston; M. Trent Herdman; Stije J. Leopold; Haruhiko Ishioka; M. A. Faiz; Nicholas M. Anstey; Nicholas P. J. Day; Md. Amir Hossain; Mallika Imwong; Arjen M. Dondorp; Charles J. Woodrow

BackgroundControl of malaria increasingly involves administration of 8-aminoquinolines, with accompanying risk of haemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Few data on the prevalence and genotypic basis of G6PD deficiency are available from Bangladesh, where malaria remains a major problem in the South (Chittagong Division). The aim of this study was to determine the prevalence of G6PD deficiency, and associated G6PD genotypes, in adults with falciparum malaria in southern Bangladesh.MethodsG6PD status was assessed via a combination of fluorescent spot testing (FST) and genotyping in 141 Bengali patients admitted with falciparum malaria to two centres in Chittagong Division from 2012 to 2014. In addition, an analysis of genomic data from 1000 Genomes Project was carried out among five healthy Indian subcontinent populations.ResultsOne male patient with uncomplicated malaria was found to have G6PD deficiency on FST and a genotype associated with deficiency (hemizygous Orissa variant). In addition, there were two female patients heterozygous for deficiency variants (Orissa and Kerala-Kalyan). These three patients had a relatively long duration of symptoms prior to admission compared to G6PD normal cases, possibly suggesting an interaction with parasite multiplication rate. In addition, one of 27 healthy local controls was deficient on FST and hemizygous for the Mahidol variant of G6PD deficiency. Examination of 1000 Genomes Project sequencing data across the Indian subcontinent showed that 19/723 chromosomes (2.63%) carried a variant associated with deficiency. In the Bengali from Bangladesh 1000 Genomes population, three of 130 chromosomes (2.31%) carried deficient alleles; this included single chromosomes carrying the Kerala-Kalyan and Orissa variants.ConclusionsIn line with other recent work, G6PD deficiency is uncommon in Bengalis in Bangladesh. Further studies of particular ethnic groups are needed to evaluate the potential risk of wide deployment of primaquine in malaria control efforts in Bangladesh.


Critical Care | 2015

The role of previously unmeasured organic acids in the pathogenesis of severe malaria.

M. Trent Herdman; Natthida Sriboonvorakul; Stije J. Leopold; Sam Douthwaite; Sanjib Mohanty; Mahtab Uddin Hassan; Richard J. Maude; Hugh W. F. Kingston; Katherine Plewes; Prakaykaew Charunwatthana; Kamolrat Silamut; Charles J. Woodrow; Kesinee Chotinavich; Md. Amir Hossain; M. Abul Faiz; Saroj K. Mishra; Natchanun Leepipatpiboon; Nicholas J. White; Nicholas P. J. Day; Joel Tarning; Arjen M. Dondorp

IntroductionSevere falciparum malaria is commonly complicated by metabolic acidosis. Together with lactic acid (LA), other previously unmeasured acids have been implicated in the pathogenesis of falciparum malaria.MethodsIn this prospective study, we characterised organic acids in adults with severe falciparum malaria in India and Bangladesh. Liquid chromatography-mass spectrometry was used to measure organic acids in plasma and urine. Patients were followed until recovery or death.ResultsPatients with severe malaria (n=138), uncomplicated malaria (n=102), sepsis (n=32) and febrile encephalopathy (n=35) were included. Strong ion gap (mean±SD) was elevated in severe malaria (8.2 mEq/L±4.5) and severe sepsis (8.6 mEq/L±7.7) compared with uncomplicated malaria (6.0 mEq/L±5.1) and encephalopathy (6.6 mEq/L±4.7). Compared with uncomplicated malaria, severe malaria was characterised by elevated plasma LA, hydroxyphenyllactic acid (HPLA), α-hydroxybutyric acid and β-hydroxybutyric acid (all P<0.05). In urine, concentrations of methylmalonic, ethylmalonic and α-ketoglutaric acids were also elevated. Multivariate logistic regression showed that plasma HPLA was a strong independent predictor of death (odds ratio [OR] 3.5, 95 % confidence interval [CI] 1.6–7.5, P=0.001), comparable to LA (OR 3.5, 95 % CI 1.5–7.8, P=0.003) (combined area under the receiver operating characteristic curve 0.81).ConclusionsNewly identified acids, in addition to LA, are elevated in patients with severe malaria and are highly predictive of fatal outcome. Further characterisation of their sources and metabolic pathways is now needed.


Emerging Infectious Diseases | 2018

Rickettsial Illnesses as Important Causes of Febrile Illness in Chittagong, Bangladesh

Hugh W. F. Kingston; Ma Hossain; Stije J. Leopold; Tippawan Anantatat; Ampai Tanganuchitcharnchai; Ipsita Sinha; Katherine Plewes; Richard J. Maude; Ma Hassan Chowdhury; Sujat Paul; Rabiul Alam Mohammed Erfan Uddin; Mohammed Abu Naser Siddiqui; Abu Shahed Md Zahed; Abdullah Abu Sayeed; Mohammed Habibur Rahman; Anupam Barua; Mohammed Jasim Uddin; Mohammed Abdus Sattar; Arjen M. Dondorp; Stuart D. Blacksell; Nicholas P. J. Day; Aniruddha Ghose; Amir Hossain; Daniel H. Paris

Scrub and murine typhus are common, treatable causes of undifferentiated febrile illnesses in hospitalized patients.


Tropical Medicine and Infectious Disease | 2018

Diagnostic Accuracy of the InBios Scrub Typhus Detect™ ELISA for the Detection of IgM Antibodies in Chittagong, Bangladesh

Stuart D. Blacksell; Hugh W. F. Kingston; Ampai Tanganuchitcharnchai; Meghna Phanichkrivalkosil; Ma Hossain; Amir Hossain; Aniruddha Ghose; Stije J. Leopold; Arjen M. Dondorp; Nicholas P. J. Day; Daniel H. Paris

Here we estimated the accuracy of the InBios Scrub Typhus Detect™ immunoglobulin M (IgM) ELISA to determine the optimal optical density (OD) cut-off values for the diagnosis of scrub typhus. Patients with undifferentiated febrile illness from Chittagong, Bangladesh, provided samples for reference testing using (i) qPCR using the Orientia spp. 47-kDa htra gene, (ii) IFA ≥1:3200 on admission, (iii) immunofluorescence assay (IFA) ≥1:3200 on admission or 4-fold rise to ≥3200, and (iv) combination of PCR and IFA positivity. For sero-epidemiological purposes (ELISA vs. IFA ≥1:3200 on admission or 4-fold rise to ≥3200), the OD cut-off for admission samples was ≥1.25, resulting in a sensitivity (Sn) of 91.5 (95% confidence interval (95% CI: 96.8–82.5) and a specificity (Sp) of 92.4 (95% CI: 95.0–89.0), while for convalescent samples the OD cut-off was ≥1.50 with Sn of 66.0 (95% CI: 78.5–51.7) and Sp of 96.0 (95% CI: 98.3–92.3). Comparisons against comparator reference tests (ELISA vs. all tests including PCR) indicated the most appropriate cut-off OD to be within the range of 0.75–1.25. For admission samples, the best Sn/Sp compromise was at 1.25 OD (Sn 91.5%, Sp 92.4%) and for convalescent samples at 0.75 OD (Sn 69.8%, Sp 89.5%). A relatively high (stringent) diagnostic cut-off value provides increased diagnostic accuracy with high sensitivity and specificity in the majority of cases, while lowering the cut-off runs the risk of false positivity. This study underlines the need for regional assessment of new diagnostic tests according to the level of endemicity of the disease given the high levels of residual or cross-reacting antibodies in the general population.


PLOS Pathogens | 2018

Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway

Weijian Ye; Marvin Chew; Jue Hou; Fritz Lai; Stije J. Leopold; Hooi Linn Loo; Aniruddha Ghose; Ashok K. Dutta; Qingfeng Chen; Eng Eong Ooi; Nicholas J. White; Arjen M. Dondorp; Peter Rainer Preiser; Jianzhu Chen

Natural killer (NK) cells provide the first line of defense against malaria parasite infection. However, the molecular mechanisms through which NK cells are activated by parasites are largely unknown, so is the molecular basis underlying the variation in NK cell responses to malaria infection in the human population. Here, we compared transcriptional profiles of responding and non-responding NK cells following exposure to Plasmodium-infected red blood cells (iRBCs) and identified MDA5, a RIG-I-like receptor involved in sensing cytosolic RNAs, to be differentially expressed. Knockout of MDA5 in responding human NK cells by CRISPR/cas9 abolished NK cell activation, IFN-γ secretion, lysis of iRBCs. Similarly, inhibition of TBK1/IKKε, an effector molecule downstream of MDA5, also inhibited activation of responding NK cells. Conversely, activation of MDA5 by liposome-packaged poly I:C restored non-responding NK cells to lyse iRBCs. We further show that microvesicles containing large parasite RNAs from iRBCs activated NK cells by fusing with NK cells. These findings suggest that NK cells are activated through the MDA5 pathway by parasite RNAs that are delivered to the cytoplasm of NK cells by microvesicles from iRBCs. The difference in MDA5 expression between responding and non-responding NK cells following exposure to iRBCs likely contributes to the variation in NK cell responses to malaria infection in the human population.


Malaria Journal | 2018

Acidosis and acute kidney injury in severe malaria

Natthida Sriboonvorakul; Aniruddha Ghose; Mahtab Uddin Hassan; Md. Amir Hossain; M. Abul Faiz; Sasithon Pukrittayakamee; Kesinee Chotivanich; Yaowalark Sukthana; Stije J. Leopold; Katherine Plewes; Nicholas P. J. Day; Nicholas J. White; Joel Tarning; Arjen M. Dondorp

BackgroundIn severe falciparum malaria metabolic acidosis and acute kidney injury (AKI) are independent predictors of a fatal outcome in all age groups. The relationship between plasma acids, urine acids and renal function was investigated in adult patients with acute falciparum malaria.MethodsPlasma and urinary acids which previously showed increased concentrations in proportion to disease severity in patients with severe falciparum malaria were quantified. Patients with uncomplicated malaria, sepsis and healthy volunteers served as comparator groups. Multiple regression and multivariate analysis were used to assess the relationship between organic acid concentrations and clinical syndromes, in particular AKI.ResultsPatients with severe malaria (n = 90), uncomplicated malaria (n = 94), non-malaria sepsis (n = 19), and healthy volunteers (n = 61) were included. Univariate analysis showed that both plasma and creatinine-adjusted urine concentrations of p-hydroxyphenyllactic acid (pHPLA) were higher in severe malaria patients with AKI (p < 0.001). Multiple regression analysis, including plasma or creatinine-adjusted urinary acids, and PfHRP2 as parasite biomass marker as independent variables, showed that pHPLA was independently associated with plasma creatinine (β = 0.827) and urine creatinine (β = 0.226). Principal component analysis, including four plasma acids and seven urinary acids separated a group of patients with AKI, which was mainly driven by pHPLA concentrations.ConclusionsBoth plasma and urine concentrations of pHPLA closely correlate with AKI in patients with severe falciparum malaria. Further studies will need to assess the potential nephrotoxic properties of pHPLA.


Open Forum Infectious Diseases | 2017

Disease Severity and Effective Parasite Multiplication Rate in Falciparum Malaria

Hugh W. F. Kingston; Aniruddha Ghose; Katherine Plewes; Haruhiko Ishioka; Stije J. Leopold; Richard J. Maude; Sanjib Paul; Benjamas Intharabut; Kamorat Silamut; Charles J. Woodrow; Nicholas P. J. Day; Kesinee Chotivanich; Nicholas M. Anstey; Amir Hossain; Nicholas J. White; Arjen M. Dondorp

Abstract Patients presenting with severe falciparum malaria in a Bangladeshi tertiary hospital had higher total parasite burden, estimated by parasitemia and plasma PfHRP2, than uncomplicated malaria patients despite shorter fever duration. This suggests that higher parasite multiplication rates (PMR) contribute to causing the higher biomass found in severe disease. Compared with patients without a history of previous malaria, patients with previous malaria carried a lower parasite biomass with similar fever duration at presentation, suggesting that host immunity reduces the PMR.


BMC Infectious Diseases | 2017

Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study

Katherine Plewes; Hugh W. F. Kingston; Aniruddha Ghose; Richard J. Maude; M. Trent Herdman; Stije J. Leopold; Haruhiko Ishioka; Md. Mahtab Uddin Hasan; Md. Shafiul Haider; Shamsul Alam; Kim A. Piera; Prakaykaew Charunwatthana; Kamolrat Silamut; Tsin W. Yeo; M. A. Faiz; Sue J. Lee; Mavuto Mukaka; Gareth D. H. Turner; Nicholas M. Anstey; L. Jackson Roberts; Nicholas J. White; Nicholas P. J. Day; Md. Amir Hossain; Arjen M. Dondorp

Collaboration


Dive into the Stije J. Leopold's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aniruddha Ghose

Chittagong Medical College Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge